ID

30398

Description

Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00878254

Lien

https://clinicaltrials.gov/show/NCT00878254

Mots-clés

Versions (1)
  1. 02/06/2018 02/06/2018 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

2 juin 2018

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Lymphoma NCT00878254

Anglais

Eligibility Lymphoma NCT00878254

1 Formulaires  
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00878254
Criteria
Description

Criteria

histologically confirmed mantle cell lymphoma
Description

Mantle cell lymphoma

Type de données

boolean

Alias
UMLS CUI [1]
C0334634
previously untreated disease
Description

Disease untreated

Type de données

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0332155
measurable or evaluable disease
Description

Measurable Disease | Evaluable Disease

Type de données

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C1516986
no cns involvement
Description

Exclusion Central Nervous System Involvement

Type de données

boolean

Alias
UMLS CUI [1,1]
C2828389
UMLS CUI [1,2]
C4050309
patient characteristics:
Description

Client Characteristics

Type de données

boolean

Alias
UMLS CUI [1]
C0815172
ecog performance status 0-2
Description

ECOG performance status

Type de données

boolean

Alias
UMLS CUI [1]
C1520224
life expectancy > 6 months
Description

Life Expectancy

Type de données

boolean

Alias
UMLS CUI [1]
C0023671
bilirubin < 3 mg/dl
Description

Serum total bilirubin measurement

Type de données

boolean

Alias
UMLS CUI [1]
C1278039
sgot and sgpt < 2.5 times upper limit of normal (unless due to lymphomatous involvement)
Description

Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Exception Etiology Lymphomatous nodal involvement

Type de données

boolean

Alias
UMLS CUI [1]
C0201899
UMLS CUI [2]
C0201836
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0015127
UMLS CUI [3,3]
C0441949
serum creatinine < 1.5 mg/dl
Description

Creatinine measurement, serum

Type de données

boolean

Alias
UMLS CUI [1]
C0201976
not pregnant or nursing
Description

Pregnancy Absent | Breast Feeding Absent

Type de données

boolean

Alias
UMLS CUI [1,1]
C0032961
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0006147
UMLS CUI [2,2]
C0332197
negative pregnancy test
Description

Pregnancy test negative

Type de données

boolean

Alias
UMLS CUI [1]
C0427780
fertile patients must use effective contraception
Description

Fertility Contraceptive methods

Type de données

boolean

Alias
UMLS CUI [1,1]
C0015895
UMLS CUI [1,2]
C0700589
no grade 3-4 cardiac failure
Description

Exclusion Heart failure New York Heart Association Classification

Type de données

boolean

Alias
UMLS CUI [1,1]
C2828389
UMLS CUI [1,2]
C0018801
UMLS CUI [1,3]
C1275491
lvef ≥ 50%
Description

Left ventricular ejection fraction

Type de données

boolean

Alias
UMLS CUI [1]
C0428772
no known history of hiv or aids
Description

Exclusion Criteria | HIV Infection | Acquired Immunodeficiency Syndrome

Type de données

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C0019693
UMLS CUI [3]
C0001175
no hepatitis or hepatitis b virus infection
Description

Exclusion Criteria | Hepatitis | Hepatitis B

Type de données

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2]
C0019158
UMLS CUI [3]
C0019163
no other concurrent active malignancy, except carcinoma in situ of the cervix and basal cell carcinoma of the skin
Description

Exclusion Cancer Other | Exception Carcinoma in situ of uterine cervix | Exception Basal cell carcinoma

Type de données

boolean

Alias
UMLS CUI [1,1]
C2828389
UMLS CUI [1,2]
C1707251
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0851140
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0007117
no psychological, familial, sociological, or geographical conditions that would prohibit treatment and/or medical follow-up required to comply with study protocol
Description

Exclusion Criteria | Mental condition Preventing Protocol Compliance | Condition Familial Preventing Protocol Compliance | Sociological Factors Preventing Protocol Compliance | Geographic Factors Preventing Protocol Compliance

Type de données

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C3840291
UMLS CUI [2,2]
C1292733
UMLS CUI [2,3]
C0525058
UMLS CUI [3,1]
C0348080
UMLS CUI [3,2]
C0241888
UMLS CUI [3,3]
C1292733
UMLS CUI [3,4]
C0525058
UMLS CUI [4,1]
C3850138
UMLS CUI [4,2]
C1292733
UMLS CUI [4,3]
C0525058
UMLS CUI [5,1]
C0017444
UMLS CUI [5,2]
C1292733
UMLS CUI [5,3]
C0525058
prior concurrent therapy:
Description

Therapeutic procedure

Type de données

boolean

Alias
UMLS CUI [1]
C0087111
no prior chemotherapy, immunotherapy, or radiotherapy for this lymphoma
Description

Exclusion Criteria | Chemotherapy Lymphoma | Immunotherapy Lymphoma | Therapeutic radiology procedure Lymphoma

Type de données

boolean

Alias
UMLS CUI [1]
C0680251
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C0024299
UMLS CUI [3,1]
C0021083
UMLS CUI [3,2]
C0024299
UMLS CUI [4,1]
C1522449
UMLS CUI [4,2]
C0024299
Retour au début de la page

Similar models

Eligibility Lymphoma NCT00878254

1 Formulaires
  1. StudyEvent: Eligibility
    1. Eligibility Lymphoma NCT00878254
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Mantle cell lymphoma
Item
histologically confirmed mantle cell lymphoma
boolean
C0334634 (UMLS CUI [1])
Disease untreated
Item
previously untreated disease
boolean
C0012634 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
Measurable Disease | Evaluable Disease
Item
measurable or evaluable disease
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
Exclusion Central Nervous System Involvement
Item
no cns involvement
boolean
C2828389 (UMLS CUI [1,1])
C4050309 (UMLS CUI [1,2])
Client Characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
Life Expectancy
Item
life expectancy > 6 months
boolean
C0023671 (UMLS CUI [1])
Serum total bilirubin measurement
Item
bilirubin < 3 mg/dl
boolean
C1278039 (UMLS CUI [1])
Aspartate aminotransferase measurement | Alanine aminotransferase measurement | Exception Etiology Lymphomatous nodal involvement
Item
sgot and sgpt < 2.5 times upper limit of normal (unless due to lymphomatous involvement)
boolean
C0201899 (UMLS CUI [1])
C0201836 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0015127 (UMLS CUI [3,2])
C0441949 (UMLS CUI [3,3])
Creatinine measurement, serum
Item
serum creatinine < 1.5 mg/dl
boolean
C0201976 (UMLS CUI [1])
Pregnancy Absent | Breast Feeding Absent
Item
not pregnant or nursing
boolean
C0032961 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Pregnancy test negative
Item
negative pregnancy test
boolean
C0427780 (UMLS CUI [1])
Fertility Contraceptive methods
Item
fertile patients must use effective contraception
boolean
C0015895 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
Exclusion Heart failure New York Heart Association Classification
Item
no grade 3-4 cardiac failure
boolean
C2828389 (UMLS CUI [1,1])
C0018801 (UMLS CUI [1,2])
C1275491 (UMLS CUI [1,3])
Left ventricular ejection fraction
Item
lvef ≥ 50%
boolean
C0428772 (UMLS CUI [1])
Exclusion Criteria | HIV Infection | Acquired Immunodeficiency Syndrome
Item
no known history of hiv or aids
boolean
C0680251 (UMLS CUI [1])
C0019693 (UMLS CUI [2])
C0001175 (UMLS CUI [3])
Exclusion Criteria | Hepatitis | Hepatitis B
Item
no hepatitis or hepatitis b virus infection
boolean
C0680251 (UMLS CUI [1])
C0019158 (UMLS CUI [2])
C0019163 (UMLS CUI [3])
Exclusion Cancer Other | Exception Carcinoma in situ of uterine cervix | Exception Basal cell carcinoma
Item
no other concurrent active malignancy, except carcinoma in situ of the cervix and basal cell carcinoma of the skin
boolean
C2828389 (UMLS CUI [1,1])
C1707251 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0851140 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0007117 (UMLS CUI [3,2])
Exclusion Criteria | Mental condition Preventing Protocol Compliance | Condition Familial Preventing Protocol Compliance | Sociological Factors Preventing Protocol Compliance | Geographic Factors Preventing Protocol Compliance
Item
no psychological, familial, sociological, or geographical conditions that would prohibit treatment and/or medical follow-up required to comply with study protocol
boolean
C0680251 (UMLS CUI [1])
C3840291 (UMLS CUI [2,1])
C1292733 (UMLS CUI [2,2])
C0525058 (UMLS CUI [2,3])
C0348080 (UMLS CUI [3,1])
C0241888 (UMLS CUI [3,2])
C1292733 (UMLS CUI [3,3])
C0525058 (UMLS CUI [3,4])
C3850138 (UMLS CUI [4,1])
C1292733 (UMLS CUI [4,2])
C0525058 (UMLS CUI [4,3])
C0017444 (UMLS CUI [5,1])
C1292733 (UMLS CUI [5,2])
C0525058 (UMLS CUI [5,3])
Therapeutic procedure
Item
prior concurrent therapy:
boolean
C0087111 (UMLS CUI [1])
Exclusion Criteria | Chemotherapy Lymphoma | Immunotherapy Lymphoma | Therapeutic radiology procedure Lymphoma
Item
no prior chemotherapy, immunotherapy, or radiotherapy for this lymphoma
boolean
C0680251 (UMLS CUI [1])
C0392920 (UMLS CUI [2,1])
C0024299 (UMLS CUI [2,2])
C0021083 (UMLS CUI [3,1])
C0024299 (UMLS CUI [3,2])
C1522449 (UMLS CUI [4,1])
C0024299 (UMLS CUI [4,2])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial